V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215067 | 20130222 | 1.84 | 78.8 | Palliative (P) | 2019-07-14 | 2019-07-17 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101088812 |
| 20215068 | 20130223 | 1.55 | 54.55 | Palliative (P) | 2019-07-26 | 2019-08-05 | Trial Unspecified | N | Y | TRIAL | 100778076 |
| 20215071 | 20130224 | 1.7 | 51.4 | Palliative (P) | 2018-08-05 | 2018-08-05 | Trial Unspecified | N | N | CETUXIMAB + IRINOTECAN + MDG | 101475060 |
| 20215072 | 20130225 | 1.76 | 79.05 | Palliative (P) | 2018-04-07 | 2018-07-12 | EOX | 02 | N | EOX | 100197979 |
| 20215075 | 20130226 | 1.72 | 74.7 | Palliative (P) | 2018-11-14 | 2018-11-14 | Sorafenib | 02 | N | SORAFENIB | 100698053 |
| 20215076 | 20130227 | 1.69 | 85 | Palliative (P) | 2017-08-21 | 2017-08-22 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100048467 |
| 20215077 | 20130228 | 1.54 | 58.5 | Palliative (P) | 2017-12-20 | 2018-03-28 | EOX | null | N | CETUXIMAB + IRINOTECAN + MDG | 100987567 |
| 20215078 | 20130229 | 1.8 | 103 | Palliative (P) | 2018-07-10 | 2018-08-13 | EOX | 01 | N | OXALIPLATIN + RALTITREXED | 100591288 |
| 20215079 | 20130230 | 1.6 | 69.2 | Palliative (P) | 2018-10-21 | 2018-11-17 | Sorafenib | Y | N | SORAFENIB | 101431692 |
| 20215080 | 20130231 | 1.8 | 95 | Palliative (P) | 2020-10-31 | 2020-12-13 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100493039 |
| 20215082 | 20130232 | 1.58 | 109.8 | Palliative (P) | 2019-12-15 | 2019-12-15 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101651174 |
| 20215083 | 20130233 | 1.56 | 88.2 | Palliative (P) | 2019-10-10 | 2020-01-03 | CETUXIMAB + IRINOTECAN + MDG | N | Y | CETUXIMAB + IRINOTECAN + MDG | 101425702 |
| 20215084 | 20130234 | 1.78 | 53 | Palliative (P) | 2019-07-29 | 2019-09-03 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100017471 |
| 20215089 | 20130235 | 1.78 | 86.4 | 03 | 2020-05-09 | 2020-08-05 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100671897 |
| 20215090 | 20130236 | 1.75 | 50 | Palliative (P) | 2018-01-02 | 2018-01-16 | Capecitabine 42days + RT | null | N | CAPECITABINE + RT | 101806635 |
| 20215094 | 20130237 | 1.77 | 56 | Palliative (P) | 2018-08-28 | 2018-09-15 | EOX | N | N | CAPECITABINE + RT | 100223970 |
| 20215097 | 20130238 | 1.69 | 84.25 | Neo-adjuvant (N) | 2015-12-06 | 2016-12-06 | EOX | 2 | N | TRIAL | 101284377 |
| 20215098 | 20130239 | 1.72 | 65.4 | null | 2021-11-22 | 2021-11-24 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100080769 |
| 20215101 | 20130240 | 1.67 | 64 | Palliative (P) | 2017-12-03 | 2017-12-04 | EOX | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 101338233 |
| 20215106 | 20130241 | 1.59 | 107 | Palliative (P) | 2018-11-01 | 2018-11-23 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101314334 |
| 20215107 | 20130242 | 1.6 | 37.9 | Palliative (P) | 2018-12-20 | 2018-12-27 | EOX | N | N | SORAFENIB | 100046321 |
| 20215108 | 20130243 | 1.58 | 61.7 | Palliative (P) | 2017-07-08 | 2017-07-24 | EOX | N | N | CAPECITABINE + RT | 101198685 |
| 20215109 | 20130244 | 1.51 | 67.5 | Curative (C) | 2020-03-11 | 2020-07-12 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101705105 |
| 20215113 | 20130245 | 1.55 | 82.8 | Palliative (P) | 2017-11-16 | 2018-02-26 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101129584 |
| 20215115 | 20130246 | 1.72 | 53.75 | Neo-adjuvant (N) | 2019-01-05 | 2019-01-05 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101210331 |
| 20215119 | 20130247 | 1.58 | 49.3 | null | 2018-10-09 | 2018-10-10 | IRINOTECAN + MDG + PANITUMUMAB | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101627672 |
| 20215121 | 20130248 | 1.85 | 66.4 | Palliative (P) | 2020-02-19 | 2020-02-19 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100546650 |
| 20215125 | 20130249 | 1.72 | 99.5 | null | 2018-01-08 | 2018-04-14 | EOX | 02 | Y | EOX | 100798125 |
| 20215126 | 20130250 | 1.7 | 79 | Palliative (P) | 2018-07-15 | 2018-07-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101584161 |
| 20215127 | 20130251 | 1.82 | 102.9 | Adjuvant (A) | 2014-01-05 | 2014-02-02 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 1 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101281008 |
| 20215134 | 20130252 | 1.88 | 51.5 | Palliative (P) | 2017-12-19 | 2018-06-24 | EOX | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100202876 |
| 20215137 | 20130253 | 1.9 | 62.9 | Palliative (P) | 2019-12-30 | 2020-03-16 | EOX | 02 | N | CAPECITABINE + RT | 100128164 |
| 20215138 | 20130254 | 1.57 | 102 | Palliative (P) | 2016-09-06 | 2016-09-07 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101099914 |
| 20215142 | 20130255 | 1.6 | 72.4 | Palliative (P) | 2016-11-29 | 2016-12-13 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 101810485 |
| 20215145 | 20130256 | 1.81 | null | Neo-adjuvant (N) | 2017-07-24 | 2017-08-11 | Sorafenib | 02 | N | SORAFENIB | 100366581 |
| 20215146 | 20130257 | 1.79 | 84.3 | Palliative (P) | 2017-02-20 | 2017-02-23 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 100094289 |
| 20215154 | 20130258 | 1.76 | 62.9 | Palliative (P) | 2016-04-13 | 2017-11-24 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100575560 |
| 20215156 | 20130259 | 1.59 | 51 | Palliative (P) | 2019-05-14 | 2019-05-20 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101497143 |
| 20215157 | 20130260 | 1.77 | 78 | Palliative (P) | 2019-10-25 | 2019-10-26 | EOX | N | N | EOX | 101243063 |
| 20215159 | 20130261 | 1.8 | 61.6 | Palliative (P) | 2019-10-16 | 2019-10-30 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101172881 |
| 20215160 | 20130262 | 1.69 | 85.5 | Palliative (P) | 2020-11-26 | 2020-12-04 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101436141 |
| 20215162 | 20130263 | 1.55 | 46.1 | Palliative (P) | 2016-08-08 | 2018-12-08 | GO2 TRIAL | Y | null | TRIAL | 101419907 |
| 20215163 | 20130264 | 1.74 | 120 | Palliative (P) | 2019-12-28 | 2020-01-04 | Trial Unspecified | Y | N | TRIAL | 100398168 |
| 20215165 | 20130265 | 1.54 | 61 | Palliative (P) | 2020-07-20 | 2020-07-27 | CAPECITABINE + RT | Y | N | CAPECITABINE + RT | 100187047 |
| 20215166 | 20130266 | 0 | 46.9 | Palliative (P) | 2021-01-24 | 2021-08-11 | Sorafenib | 02 | N | SORAFENIB | 101788033 |
| 20215169 | 20130267 | 1.56 | 60 | Palliative (P) | 2017-12-06 | 2017-12-06 | EOX | N | N | TRIAL | 100785299 |
| 20215170 | 20130268 | 1.69 | 75 | Palliative (P) | 2021-07-19 | 2021-07-22 | EOX | N | Y | CETUXIMAB + IRINOTECAN + MDG | 101532868 |
| 20215175 | 20130269 | 1.72 | 44 | Curative (C) | 2016-06-29 | 2017-09-11 | EOX | Y | Y | TRIAL | 101254915 |
| 20215176 | 20130270 | 1.74 | null | Palliative (P) | 2019-11-10 | 2019-12-01 | Capecitabine 35days + RT | 99 | N | SORAFENIB | 101713117 |
| 20215177 | 20130271 | 1.57 | 78 | Palliative (P) | 2017-07-18 | 2017-08-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100625680 |